𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Single-blind randomised controlled trial of chemonucleolysis and manipulation in the treatment of symptomatic lumbar disc herniation

✍ Scribed by A. K. Burton; K. Malcolm Tillotson; John Cleary

Publisher
Springer
Year
2000
Tongue
English
Weight
50 KB
Volume
9
Category
Article
ISSN
0940-6719

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Venlafaxine versus nortriptyline in the
Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial
✍ Rob M. Kok; Willem A. Nolen; Thea J. Heeren πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 125 KB πŸ‘ 2 views

## Abstract ## Background The majority of the trials in the elderly are outpatient trials which excluded psychotic patients and patients with common comorbid physical disorders. Consequently information is lacking about the more complex cases of elderly depressed patients, as found in inpatient wa

The effect of staff training on the use
The effect of staff training on the use of restraint in dementia: a single-blind randomised controlled trial
✍ I. Testad; A. M. Aasland; D. Aarsland πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 56 KB

## Abstract ## Background Use of restraint amongst institutionalised elderly with dementia and problem behaviour not only remains widespread, but also appears to be accepted as inevitable. ## Objective The aim of this study was to reduce problem behaviour and the use of restraint in demented pat

Randomised, double-blind, placebo-contro
Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia
✍ Susan H. Fox; Mark Kellett; A. Peter Moore; Alan R. Crossman; Jonathan M. Brotch πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 149 KB πŸ‘ 1 views

## Abstract Cannabis may have medicinal uses in a variety of diseases. The neural mechanisms underlying dystonia involve abnormalities within the basal gangliaβ€”in particular, overactivity of the lateral globus pallidus (GPl). Cannabinoid receptors are located presynaptically on GABA terminals withi

Mirtazapine add-on therapy in the treatm
Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial
✍ Michael Berk; Clarissa S. Gama; Suresh Sundram; Harry Hustig; Les Koopowitz; Rus πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 78 KB πŸ‘ 1 views

## Abstract ## Objective Schizophrenia is a multifaceted illness with positive, negative and cognitive symptom domains. Standard treatments often focus on positive symptoms and may not adequately relieve other symptoms. Previous studies have suggested a role for mirtazapine in schizophrenia, parti

Efficacy of nefazodone in the treatment
Efficacy of nefazodone in the treatment of neuroleptic induced extrapyramidal side effects: a double-blind randomised parallel group placebo-controlled trial
✍ Dora Wynchank; Michael Berk πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 56 KB

## Abstract Many atypical antipsychotics show antagonism at both serotonergic and dopaminergic neurones and show fewer extrapyramidal side effects (EPS). Nefazodone blocks postsynaptic 5HT~2A~ receptors and weakly inhibits serotonin reuptake. This study aimed to elucidate the role of nefazodone in